What is the effect of Telmisartan (Angiotensin II receptor antagonist) on menstrual function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Effect of Telmisartan on Menstrual Function

There are no research papers to assist in answering this question, as the provided studies focus on the effects of telmisartan on hypertension, metabolic syndrome, and renal function, but do not mention its impact on menstrual function.

Key Findings on Telmisartan

  • Telmisartan is an angiotensin II receptor antagonist used in the management of hypertension 1, 2, 3
  • It has a partial PPARγ-agonistic effect and agonist activity on PPARα and PPARδ receptors, which may be beneficial in treating metabolic syndrome 1
  • Telmisartan has been shown to be effective in reducing blood pressure and slowing the progression of renal dysfunction 2, 4
  • It has a long-lasting antihypertensive effect and is well-tolerated in patients with mild to moderate hypertension 2, 5

Mechanism of Action

  • Telmisartan binds to angiotensin II type 1 receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle 2, 3
  • It has a slow dissociation rate from AT1 receptors, which contributes to its insurmountable antagonism 5

References

Research

Effects of telmisartan on metabolic syndrome components: a comprehensive review.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2024

Research

Telmisartan.

Profiles of drug substances, excipients, and related methodology, 2015

Research

Potential protective effects of telmisartan on renal function deterioration.

Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.